Huntington's Disease: The Value of Transcranial Meganetic Stimulation

E-ISSN： 1875-533x|17|23|2482-2491

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.23, 2010-08, pp. : 2482-2491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Value of Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Anxiety Disorders: An Integrative Review

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 5, 2011-08 ,pp. : 610-620

Bentham Science Publishers

Access to resources Recommend Favorite

Transcranial Magnetic Stimulation in Clinical Pharmacology

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 8, Iss. 4, 2008-12 ,pp. : 234-240

Bentham Science Publishers

Access to resources Recommend Favorite

Repetitive Transcranial Magnetic Stimulation for ALS

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 3, 2010-07 ,pp. : 331-334

Bentham Science Publishers

Access to resources Recommend Favorite

Mouse models of Huntington's disease

By Menalled L.B. Chesselet M.-F.

Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. : 32-39

Elsevier

Access to resources Recommend Favorite

The Endocannabinoid System and Huntington's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 335-347

Bentham Science Publishers

Access to resources Recommend Favorite